Compare TY & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TY | MANE |
|---|---|---|
| Founded | 1929 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | N/A | N/A |
| Metric | TY | MANE |
|---|---|---|
| Price | $32.08 | $63.55 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $78.33 |
| AVG Volume (30 Days) | 51.8K | ★ 415.5K |
| Earning Date | 01-01-0001 | 03-30-2026 |
| Dividend Yield | ★ 3.36% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 4.78 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.71 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.08 | $36.26 |
| 52 Week High | $35.05 | $69.41 |
| Indicator | TY | MANE |
|---|---|---|
| Relative Strength Index (RSI) | 50.38 | 61.45 |
| Support Level | $31.80 | $54.77 |
| Resistance Level | $32.09 | $69.41 |
| Average True Range (ATR) | 0.63 | 5.75 |
| MACD | 0.10 | -0.35 |
| Stochastic Oscillator | 71.98 | 59.02 |
Tri-Continental Corp is a closed-end management investment company. It invests to produce future growth of both capital and income while providing reasonable current income. The fund is divided into two equal segments namely, the equity segment uses quantitative models to select individual stocks whereas the Flexible capital income segment invests across a company's investable capital structure, including stocks, bonds, and convertible securities. The Fund invests in a range of sectors, which include consumer discretionary, consumer staples, energy, financials, healthcare, industrials, information technology, industrials, materials, real estate, telecommunication services, utilities, aerospace and defense, banking, chemicals, and others.
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.